What Happened?
San Diego, CA-based Janux-Therapeutics Appointed David Campbell as President and Chief Executive Officer
About the Company
Janux Therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer.
About the Person
David Campbell is President and Chief Executive Officer at Janux Therapeutics. Previously, David held various senior HR leadership roles in the industry.
Info Source
News
Short Profile